Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children

Lisa C. Martial, Rob E. Aarnoutse, Michiel F. Schreuder, Stefanie S. Henriet, Roger J.M. Brüggemann, Manuela A. Joor

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

47 Citaten (Scopus)

Samenvatting

Dried blood spot (DBS) sampling for the purpose of therapeutic drug monitoring can be an attractive alternative for conventional blood sampling, especially in children. This study aimed to compare all costs involved in conventional sampling versus DBS home sampling in two pediatric populations: renal transplant patients and hemato-oncology patients. Total costs were computed from a societal perspective by adding up healthcare cost, patient related costs and costs related to loss of productivity of the caregiver. Switching to DBS home sampling was associated with a cost reduction of 43% for hemato-oncology patients (€277 to €158) and 61% for nephrology patients (€259 to €102) from a societal perspective (total costs) per blood draw. From a healthcare perspective, costs reduced with 7% for hemato-oncology patients and with 21% for nephrology patients. Total savings depend on the number of hospital visits that can be avoided by using home sampling instead of conventional sampling.

Originele taal-2Engels
Artikelnummere0167433
TijdschriftPLoS ONE
Volume11
Nummer van het tijdschrift12
DOI's
StatusGepubliceerd - dec. 2016
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children'. Samen vormen ze een unieke vingerafdruk.

Citeer dit